Intuitive Surgical, Inc.
$487.85
▲
8.14%
2026-04-22 10:12:13
www.intuitive.com
NMS: ISRG
Explore Intuitive Surgical, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$174.03 B
Current Price
$487.85
52W High / Low
$603.88 / $427.84
Stock P/E
62.04
Book Value
$50.19
Dividend Yield
—
ROCE
15.96%
ROE
16.69%
Face Value
—
EPS
$7.87
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
17,021
Beta
1.68
Debt / Equity
0.95
Current Ratio
4.88
Quick Ratio
3.96
Forward P/E
39.43
Price / Sales
15.9
Enterprise Value
$154.38 B
EV / EBITDA
43.39
EV / Revenue
15.34
Rating
Buy
Target Price
$599.24
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
Cons
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | LeMaitre Vascular, Inc. | $115 | 44.97 | $2.6 B | 0.87% | 11.72% | 15.8% | $118.01 / $78.01 | $17.28 |
| 2. | Ekso Bionics Holdings, Inc. | $11.38 | — | $40.55 M | — | -116.13% | -1.08% | $13.5 / $2.73 | $2.54 |
| 3. | Baxter International Inc. | $18.8 | — | $9.79 B | 0.21% | 1.04% | -13.71% | $32.68 / $15.73 | $11.92 |
| 4. | Nephros, Inc. | $3.07 | 27.37 | $32.68 M | — | 10.54% | 12.71% | $6.42 / $1.64 | $0.96 |
| 5. | Femasys Inc. | $0.42 | — | $25.6 M | — | -460.52% | -4.56% | $1.29 / $0.31 | $0.1 |
| 6. | GlucoTrack, Inc. | $0.78 | — | $1.55 M | — | -524.96% | 381.2% | $15.9 / $0.62 | $3.06 |
| 7. | Avantor, Inc. | $8.5 | — | $5.76 B | — | 5.22% | -9.2% | $16.17 / $7.26 | $8.24 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 2.87 B | 2.51 B | 2.44 B | 2.25 B | 2.41 B | — |
| Operating Profit | 864.3 M | 759.7 M | 743.4 M | 578.1 M | 734.9 M | — |
| Net Profit | 794.8 M | 704.4 M | 658.4 M | 698.4 M | 685.7 M | — |
| EPS in Rs | 2.24 | 1.98 | 1.85 | 1.97 | 1.93 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 10.06 B | 8.35 B | 7.12 B | 6.22 B |
| Operating Profit | 2.95 B | 2.35 B | 1.77 B | 1.58 B |
| Net Profit | 2.86 B | 2.32 B | 1.8 B | 1.32 B |
| EPS in Rs | 8.04 | 6.54 | 5.06 | 3.72 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 20.46 B | 18.74 B | 15.44 B | 12.97 B |
| Total Liabilities | 2.52 B | 2.21 B | 2.04 B | 1.86 B |
| Equity | 17.82 B | 16.43 B | 13.31 B | 11.04 B |
| Current Assets | 9.78 B | 7.11 B | 7.89 B | 6.25 B |
| Current Liabilities | 2.01 B | 1.75 B | 1.66 B | 1.42 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 3.03 B | 2.42 B | 1.81 B | 1.49 B |
| Investing CF | 665.8 M | -3.27 B | -360.1 M | 1.37 B |
| Financing CF | -2.36 B | 150.9 M | -287.6 M | -2.57 B |
| Free CF | 2.49 B | 1.3 B | 749.6 M | 958.4 M |
| Capex | -539.8 M | -1.11 B | -1.06 B | -532.4 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 17.24% | 14.49% | — | — |
| Earnings Growth % | 29.18% | 35.98% | — | — |
| Profit Margin % | 27.81% | 25.24% | 21.25% | — |
| Operating Margin % | 28.12% | 24.8% | 25.35% | — |
| Gross Margin % | 67.46% | 66.39% | 67.44% | — |
| EBITDA Margin % | 34.11% | 31.18% | 31.23% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2021-10-05 | 1:3 |